Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dronedarone vs amiodarone after catheter ablation for persistent atrial fibrillation
ChiCTR2100052758Phase 4Recruiting
- Sponsor
- Fuwai Hospital, Chinese Academy of Medical Sciences, Shenzhen Hospital
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Atrial fibrillation (AFib) comparing dronedarone with Active control: amiodarone (2 arms). Primary endpoint: First recurrence of atrial fibrillation/atrial tachycardia >30 seconds within 3 months after ablation. Started Dec 2021; status: recruiting.
02
Drugs
dronedaroneamiodarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on ChiCTR2100052758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052758.